Mucommune, LLC
Biotechnology Company
Why pick this one
Mucommune, founded in 2016, is advancing unique innovations in immunoengineering and has developed an in vivo CAR-T therapy for cancer.
Best for
- biotechnology research in immunoengineering
- developing mucosal therapeutics
Look elsewhere if
- looking for traditional pharmaceutical services
- seeking budget-friendly options for pharmaceutical solutions
Specialties
- in vivo CAR-T therapy development
- female reproductive health therapeutics
- polymer immunogenicity
Certifications
- ARPA-H funding
What makes them different
- Founded from research at Johns Hopkins and UNC Chapel Hill
- Developing first-in-class platforms for female reproductive health
- Licenses mucosal antibody IP from UNC
- Spun off Inhalon Biopharma, which raised over $50M
- Serves
- Research Triangle
Distilled from this business's own website.
Contact & Location
- Address
- 5151 McCrimmon Pkwy, Morrisville, NC 27560-0177
- Phone
- +19192389291
- Website
- https://www.mucommune.com/
- intl-segmenter@11.7.10
Services
- biotechnology research and development
- immunoengineering
- drug and gene delivery
- cancer therapy